In current practice, whether an act of administrative approval can be accommodated under Bolar exemption, has not been generally agreed upon among National Medical Products Administration (NMPA).
The number of trademark applications in China has increased rapidly, which result in large demand for trademark registration and the change of registration.
京公网安备 11010802020770号